SCHEMBL1992305

SCHEMBL1992305

Cc1c([AsH2])c2ccccc2oc1=O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.62
ALDH1A1 P00352 8/20 0.48
GAA P10253 6/20 0.48
HSD17B10 Q99714 4/20 0.47
MAPT P10636 3/20 0.47
CYP3A4 P08684 3/20 0.47
HPGD P15428 3/20 0.47
GLA P06280 1/20 0.47
PGAM1 P18669 1/20 0.47
MAOA P21397 1/20 0.47
CASP1 P29466 1/20 0.47
CASP7 P55210 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CA12 O43570 2/20 0.45
CA9 Q16790 2/20 0.45
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
ALDH2 P05091 1/20 0.44
MAPK1 P28482 2/20 0.43
ABCB11 O95342 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2450078 0.84 KDM4E (0.71) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL27947283 0.77 KDM4E (0.62) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL27628922 0.77 KDM4E (0.62) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL94134 0.77 GAA (0.69) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL29695571 0.77 KDM4E (1.00) KDM4EALDH1A1MAPTCYP3A4SMN1; SMN2
SCHEMBL5459905 0.77 KDM4E (1.00) KDM4EALDH1A1MAPTCYP3A4SMN1; SMN2
Isopropyl Alcohol SCHEMBL11096119 0.76 KDM4E (0.66) KDM4EGAAHSD17B10CASP7CA12
Acetic Acid SCHEMBL15653002 0.76 KDM4E (0.66) KDM4EALDH1A1HSD17B10MAPTCYP3A4
SCHEMBL1660190 0.76 GAA (0.70) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL19484976 0.74 CYP1B1 (0.60) KDM4EALDH1A1GAAHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2337784-A1 MACROCYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS Bristol-Myers Squibb Company (US) 2011-06-29 EP disclosed
WO-2010036871-A1 MACROCYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2010-04-01 WO disclosed
WO-2006023209-A2 USES OF NOTCH RECEPTORS, NOTCH LIGANDS, AND NOTCH MODULATORS IN METHODS RELATED TO METABOLIC DISEASES THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH (US) 2006-03-02 WO disclosed